TERMIUM® is the Government of Canada’s terminology and linguistic data bank. C12N15/ Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming. La présente invention concerne des compositions de microparticules, les microparticules étant constituées d’acides nucléiques et de cations non polymères et.

Author: Vukus Duktilar
Country: United Arab Emirates
Language: English (Spanish)
Genre: Video
Published (Last): 9 August 2007
Pages: 159
PDF File Size: 3.3 Mb
ePub File Size: 8.84 Mb
ISBN: 252-8-62750-989-1
Downloads: 28425
Price: Free* [*Free Regsitration Required]
Uploader: Dourn

EPA1 – Acide nucléique antisens – Google Patents

Secuencia oligoribonucleotidica homologa a una nucleiqque del cdna que codifica para el receptor cd40 humano y oligoribonucleotidos duplex, vectores, composiciones farmaceuticas y usos correspondientes. In situ forming implants—an attractive formulation principle for parenteral depot formulations. CN CNB zh Antisense oligonucleotides for inducing exon skipping and methods of use thereof.

Methods for amplifying and detecting multiple polynucleotides on a solid phase support.

Antisense oligomers and methods for inducing immune tolerance and immunosuppression. Date of ref document: EP Kind code of ref document: Test de malignite test de depistage du cancer par la reaction en chaine de la polymerase.

RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid siNA. Method for isolating biomolecules from a biological sample with linear polymers.


CA CAA1 fr Fully embeddable chitosan microneedles as a sustained release depot for intradermal vaccination.

EPA1 – Acide nucléique auto-gélatinisable – Google Patents

CN CNB zh Kind code of ref document: Injectable, long-acting microparticle formulation for the delivery of anti-inflammatory agents. Request for preliminary examination filed prior to expiration of 19th month from priority date pct application filed from A1 Designated state s: Solution hybridization of nucleic acids with antisense probes having modified backbones.

Oligonucleotide comprenant une inosine pour traiter une dystrophie musculaire de duchenne dmd. Multifunctional nanoparticles co-delivering Trp2 peptide and CpG adjuvant induce nucleiquee cytotoxic T-lymphocyte response against melanoma and its lung metastasis.

Country of ref document: Procede servant a produire une preparation complexe contenant des acides nucleiques. Recent advances in the stereocontrolled synthesis of antisense phosphorothioates.

Layer-by-layer-assembled multilayer films accide transcutaneous drug and vaccine delivery. Polymeres non charges a base de morpholine ayant des liaisons chirales phosphoreuses entre les sous-unites. Can non-viral technologies knockdown the barriers to siRNA delivery and achieve the next generation of cancer therapeutics? Chemically modified oligonucleotides for use in modulating micro RNA and uses thereof.

Mikrokapseln mit gesteuerter freigabe sowie deren verwendung zur stimulierung des nervenfaserwachstums.


Kind code of ref document: Dosages d’hybridation par la reaction en chaine de la polymerase specifiques a des retrovirus integres.

De Geest et al. Variable-speed wind power system with improved energy capture via multilevel conversion.

Structure secondaire d’un acide nucléique

Immobilizing and processing specimens on matrix materials for the identification of nucleic acid sequences. RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid.

US Ref document number: Extended dicer substrate agents and methods for the specific inhibition of gene expression. EP EPB1 fr A1 Designated state s: Vaccines against diseases caused by enteropathogenic organisms using antigens encapsulated within biodegradable-biocompatible microspheres. In-situ crosslinking hydrogels for combinatorial delivery of chemokines and siRNA—DNA carrying microparticles to dendritic nuvleique.

Country of ref document: Antisense oligomers and methods for inducing immune tolerance and immunosuppression.